Independent Medical Education Request for Proposals - MOGAD
Supports educational projects that advance clinical knowledge, diagnostics, and care practices for Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD) among healthcare professionals.
Funder: Roche
Due Dates: July 24, 2026 (Full grant proposal submission deadline for MOGAD RFP)
Funding Amounts: Up to $200,000 per project; single-year awards typical.
Summary: Supports independent medical education projects to advance knowledge and care in Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD).
Key Information: Only U.S.-based, accredited CME/CE providers are eligible; proposals must be submitted via the Genentech Funding Request System.
Description
This opportunity invites accredited U.S.-based educational providers to submit proposals for independent medical education projects focused on Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD). The goal is to support initiatives that address knowledge gaps, improve diagnostic accuracy, and enhance patient care among healthcare professionals managing MOGAD. Funded projects should deliver evidence-based, up-to-date educational content and demonstrate measurable impact on clinical practice or patient outcomes.
